Lowenthal R M, Cohen M L, Atkinson K, Biggs J C
Clinical Haematology and Medical Oncology Unit, Royal Hobart Hospital, Hobart, Tasmania, Australia.
J Rheumatol. 1993 Jan;20(1):137-40.
We describe the induction of sustained remissions and possible cure of severe erosive rheumatoid arthritis (RA) by bone marrow transplantation (BMT) in 2 patients. BMT was used to treat severe aplastic anemia which was caused by gold in one case and D-penicillamine in the other. In the 8 and 6 years since the transplants (representing 8 and 4 years since cessation of all immunosuppressive therapy, respectively), the RA in each case has been completely quiescent. Although short term remission of severe RA following BMT has been reported, these are the first cases for which prolonged followup has been available. This experience raises the question of the role of BMT itself as a therapeutic option for patients with uncontrolled destructive synovitis.
我们描述了2例通过骨髓移植(BMT)诱导重度侵蚀性类风湿关节炎(RA)持续缓解并可能治愈的病例。BMT用于治疗1例由金制剂引起、另1例由青霉胺引起的重度再生障碍性贫血。在移植后的8年和6年(分别代表停止所有免疫抑制治疗后的8年和4年)里,每例患者的RA均完全缓解。虽然此前已有BMT后重度RA短期缓解的报道,但这是首批有长期随访结果的病例。这一经验引发了关于BMT本身作为未控制的破坏性滑膜炎患者治疗选择的作用的问题。